This is a non-core endpoint: only basic statistics are computed.
Phlebitis and thrombophlebitis of other sites, drug-induced
PHLEBI_THROMBOP_OTHER_SITES
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
1 out of 7 registries used, show all original rules.
20
Check minimum number of events None
20
Include endpoints None
20
Remove individuals based on genotype QC
19
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Phlebitis and thrombophlebitis of other sites, drug-induced based on the number of shared cases.
Broader endpoints:
- Phlebitis and thrombophlebitis (not including DVT)
- Venous thromboembolism
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)
- Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified
- Cardiovascular diseases (excluding rheumatic etc)
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 19 | 13 | 6 |
Unadjusted prevalence (%) | 0.00 | 0.01 | 0.00 |
Mean age at first event (years) | 47.18 | 42.70 | 56.88 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: PHLEBI_THROMBOP_OTHER_SITES – Phlebitis and thrombophlebitis of other sites, drug-induced
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Phlebitis and thrombophlebitis of other sites, drug-induced
↥Endpoint not on priority list, no data to show.